Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
resmed.com

See what CB Insights has to offer

Investments

4

Portfolio Exits

1

Partners & Customers

10

Service Providers

1

About ResMed

ResMed (NYSE: RMD) (ASX: RMD) provides development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing.

ResMed Headquarter Location

9001 Spectrum Center Boulevard

San Diego, California, 92123,

United States

877-389-8868

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ResMed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find ResMed in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

ResMed Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ResMed Rank

Research containing ResMed

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned ResMed in 4 CB Insights research briefs, most recently on May 26, 2021.

Latest ResMed News

Australian sharemarket resumes downward spiral after inflation data spooks Wall Street

May 12, 2022

Alex DruceNCA NewsWire Wednesday’s reprieve appears to have been fleeting for ASX investors with the local sharemarket resuming a worrying three-week spiral at Thursday’s open. The benchmark ASX 200 fell by as much as 82.8 points, or 1.2 per cent, in the first hour to dip back below the key 7000 level and continue what has been a poor run of form. The local index managed to stem its recent savage losses on Wednesday thanks to gains for large mining companies such as BHP, Rio Tinto and Fortescue Metals. But not even the iron ore contingent could lift the bourse into positive territory in morning trade. Much like in the US, local tech stocks were hit hard. Afterpay owner Block Inc plunged by nearly 20 per cent to $102 while accounting software firm Xero slumped 9.8 per cent to $78.12, its lowest since April 2020 when it was recovering from the Covid-19 sell-off. Camera Icon Energy and materials stocks were helping prop up the index after a rebound in commodity prices, but the market was also being weighed down by banking stocks, consumer firms such as Woolworths, Wesfarmers and Coles, and healthcare names such as CSL and Resmed. NCA NewsWire/Flavio Brancaleone Credit: News Corp Australia Altium dropped 8.1 per cent to $2781, Megaport was 6 per cent down at $6.85, Airtasker fell 4.4 per cent to 43 cents, and Zip Co was 3.8 per cent lower at 96.2 cents. Energy and materials stocks were helping prop up the index after a rebound in commodity prices. But the market was also being weighed down by banking stocks, consumer firms such as Woolworths, Wesfarmers and Coles, and healthcare names such as CSL and Resmed. The ASX 200 was last 0.8 per cent down at 7005.6, having slipped as low as 6981.9. Mounting inflationary pressures around the world have triggered a steep central bank hiking cycle, something which has dented the appeal of riskier assets such as shares. Strict Covid-19 lockdowns in China have also cruelled the value of Australia’s resources sector, contributing to a near nine per cent decline to two-month lows on Tuesday. Traders on Thursday morning took their cue from Wall Street, where stocks tumbled overnight on worrying inflation data. IG Markets analyst Hebe Chen said US consumer prices rose at a slower rate in April – easing from 8.5 per cent to 8.3 per cent – but impatient traders were not happy with the pace. Many fear that with inflation remaining near 40-year highs the US Fed now has no choice but to deliver a bigger 75 basis-point rate hike, having seemingly taken this option off the table. Camera Icon Mounting inflationary pressures around the world have triggered a steep central bank hiking cycle, something which has dented the appeal of riskier assets such as shares. NCA Newswire/ Gaye Gerard Credit: News Corp Australia “The (data) that came out last night was still stronger than the forecast … suggesting the price pressure will persist at higher levels for longer even if it’s already peaked,” Ms Chen said. As is typical when inflation is high and steeper rate hikes loom, growth stocks have been badly affected. This included an 8.3 per cent dive for Elon Musk’s Tesla, a 5.2 per cent drop for gadget maker Apple, a 3.2 per cent fall for Amazon, and a 6.4 per cent decline for Netflix Fellow Nasdaq giant Meta Platforms fell 4.5 per cent, Microsoft was down 3.3 per cent, and Google parent Alphabet lost 0.5 per cent.

ResMed Investments

4 Investments

ResMed has made 4 investments. Their latest investment was in Lenus as part of their Seed on November 11, 2021.

CBI Logo

ResMed Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/23/2021

Seed

Lenus

Yes

1

2/12/2020

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

3/27/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/23/2009

Series B

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/23/2021

2/12/2020

3/27/2019

7/23/2009

Round

Seed

Series C - II

Series A

Series B

Company

Lenus

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

0

ResMed Portfolio Exits

1 Portfolio Exit

ResMed has 1 portfolio exit. Their latest portfolio exit was Nyxoah on September 09, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/9/2020

IPO

$99M

5

Date

9/9/2020

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

5

ResMed Acquisitions

17 Acquisitions

ResMed acquired 17 companies. Their latest acquisition was Ectosense on October 01, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/1/2021

Other

$99M

$0.01M

Acquired

1

1/31/2020

$99M

Acquired

1

3/7/2019

$99M

Acquired

2

12/3/2018

Series D

Subscribe to see more

$99M

$99M

Subscribe to see more

10

11/5/2018

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2021

1/31/2020

3/7/2019

12/3/2018

11/5/2018

Investment Stage

Other

Series D

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$0.01M

$99M

Note

Acquired

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

ResMed Partners & Customers

10 Partners and customers

ResMed has 10 strategic partners and customers. ResMed recently partnered with Freespira on January 1, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

1/1/2021

Partner

United States

1/15/2020

Partner

United States

IFF and SleepScore Labs Create Groundbreaking Sleep Partnership

The partnership with IFF reinforces SleepScore Labs ' commitment to ensuring consumers purchase products that not only claim to optimize sleep but also help consumers achieve a more complete , restful night 's sleep .

1

10/8/2019

Partner

United States

Cerner & ResMed Team Up to Connect Health Networks and the Home

Cerner Corporation , a global health platform and innovation company , and ResMed , a digital health company , announced a new collaboration agreement to help providers make more informed treatment decisions , control costs , and deliver seamless care across health systems to the home .

2

8/22/2019

Vendor

United States

Subscribe to see more

Subscribe to see more

10

3/28/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

1/1/2021

1/15/2020

10/8/2019

8/22/2019

3/28/2019

Type

Partner

Partner

Partner

Vendor

Partner

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

IFF and SleepScore Labs Create Groundbreaking Sleep Partnership

The partnership with IFF reinforces SleepScore Labs ' commitment to ensuring consumers purchase products that not only claim to optimize sleep but also help consumers achieve a more complete , restful night 's sleep .

Cerner & ResMed Team Up to Connect Health Networks and the Home

Cerner Corporation , a global health platform and innovation company , and ResMed , a digital health company , announced a new collaboration agreement to help providers make more informed treatment decisions , control costs , and deliver seamless care across health systems to the home .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

10

10

ResMed Service Providers

1 Service Provider

ResMed has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Counsel

General Counsel

Service Provider

Associated Rounds

Acquired

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

ResMed Team

13 Team Members

ResMed has 13 team members, including current President, Raj Sodhi.

Name

Work History

Title

Status

Peter C. Farrell

Founder

Current

Raj Sodhi

President

Current

Caspar Graf Stauffenberg

Chief Executive Officer

Former

Michael Taube

Chief Executive Officer

Former

Jim Hollingshead

President

Former

Name

Peter C. Farrell

Raj Sodhi

Caspar Graf Stauffenberg

Michael Taube

Jim Hollingshead

Work History

Title

Founder

President

Chief Executive Officer

Chief Executive Officer

President

Status

Current

Current

Former

Former

Former

You May Also Like

Withings Logo
Withings

Withings creates smart products and apps to help people across the world take care of their health and well-being. By extending the capabilities of an object through network resources, Withings provides access to computing and storage facility at no extra cost, turning objects into smart connected devices.

Dozee Logo
Dozee

Turtle Shell Technologies develops Dozee, a contactless health monitor that silently tracks users' heart, respiration, and sleep patterns while they sleep. The smart algorithms also enable early detection of any health deterioration helping users to stay on top of their health.

Whoop Logo
Whoop

Whoop makes a fitness tracker that is popular with professional athletes. Whoop describes itself as a personal digital fitness and health coach and monitors sleep, strain and recovery.

Oura Logo
Oura

Oura offers a wellness ring and app designed to help users get more restful sleep and perform better by analyzing the body's sleep, activity levels, daily rhythms, and physiological responses. The company was founded in 2013 and is based in Oulu, Finland.

Empatica Logo
Empatica

Empatica is a full-stack company that designs and develops AI systems to monitor human health through wearable sensors. The company provides a platform for the forecasting, monitoring, and treatment of medical conditions.

V
VitalThings

VitalThings offers advanced contactless sensors and services for human vital signs detection and analysis. It offers a sleep monitor that analyzes nightly breathing rates and movements to feed the cloud-based services that enable advanced analysis, historical data, triggers, and notifications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.